Touchstone
Last syncOct 31, 2026, 6:54 PM ET

GEHC

Ge Healthcare Technologies Inc. Health Care X-Ray Apparatus & Tubes & Related Irradiation Apparatus S&P 500Nasdaq-100Russell 3000
$76.57Close $35.1BMarket cap $59.45 – $88.0352-week range Late-januaryNext report · estimated

Highlights

Strengths

  • Earnings growing EPS +39% year on year, faster than the quarter before (+23 pts)

Cautions

  • Not in an uptrend 3 of 8 trend conditions
  • Past its pivot 14.2% above its $67.06 pivot
  • Extended 4.4 ATR above its 50-day average

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 28, 2026
Off 12-month high 13%
1wk up 7.2% price change
1mo up 17.2% price change
12-month return up 2% market up 11% · its own down 12%
F-score 5 / 9 Mixed
Altman Z 1.92 Moderate risk
P/E 16.9× price / earnings
PEG 3.52 P/E / EPS growth
P/B 3.4× price / book
Earnings yield up 6.9% EBIT / enterprise value
Cheaper than 63% of the market · cheap
Revenue growth up 5% year on year
EPS growth up 39% latest quarter · +23 pts
Sales growth up 7% latest quarter · +1 pts
ROE up 22% return on equity
Free cash margin up 7% $1.5B FCF
D/E 0.91 long-term debt / equity
Net debt / EBITDA 1.8×
Interest cover —EBIT / interest
Piotroski tests
  • profits not fully backed by cash
  • took on more long-term debt
  • issued more shares
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • short-term liquidity improved
  • assets working harder

Trade setup

ATR% 2.7% $2.06 a day · 2×ATR $72.46
RS 59 / 99 vs the universe
Trend 3 / 8 trend template
Relative volume 1.1× vs 50-day average
Up/down volume 0.91 50 sessions
Implied move — no scheduled report
Contractions 2 17% → 6%
Pivot $67.06 14.2% above
Volume dry-up 1.1× 10 vs 50 sessions
Trend template · 3 of 8
  • Price above the 150 and 200-day averages: passes
  • 150-day average above the 200-day: fails
  • 200-day average rising for a month: fails
  • 50-day average above the 150 and 200-day: fails
  • Price above the 50-day average: passes
  • At least 30% above the 52-week low: fails
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Gross margin narrowing Gross margin fell from 41.7% to 40.0%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Oct 28, 2026
Results reaction Oct 28, 2026+8% vs market2 sessions after results
Options $781,79630.4% IV · activity

Financials

5 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $20.6B +5% on FY2024
$0 $25B FY21 FY22 FY23 FY24 FY25 FY2021 · $17.6B FY2022 · $18.3B FY2023 · $19.6B FY2024 · $19.7B FY2025 · $20.6B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $2.1B +5% on FY2024
$0 $2.5B FY21 FY22 FY23 FY24 FY25 FY2021 · $2.2B FY2022 · $1.9B FY2023 · $1.6B FY2024 · $2.0B FY2025 · $2.1B
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $1.5B -3% on FY2024
$0 $2B FY21 FY22 FY23 FY24 FY25 FY2021 · $1.4B FY2022 · $1.8B FY2023 · $1.7B FY2024 · $1.6B FY2025 · $1.5B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 40%
  • Net 10%
  • Free cash 7%
0% 50% FY21 FY22 FY23 FY24 FY25 FY2021 · Gross 41% · Net 13% · Free cash 8% FY2022 · Gross 39% · Net 10% · Free cash 10% FY2023 · Gross 41% · Net 8% · Free cash 9% FY2024 · Gross 42% · Net 10% · Free cash 8% FY2025 · Gross 40% · Net 10% · Free cash 7%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $5.0B net debt
  • Cash
  • Long-term debt
$0 $10B FY21 FY22 FY23 FY24 FY25 FY2021 · Cash $561.0M FY2022 · Cash $1.4B · Long-term debt $8.2B FY2023 · Cash $2.5B · Long-term debt $8.4B FY2024 · Cash $2.9B · Long-term debt $7.4B FY2025 · Cash $4.5B · Long-term debt $9.5B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 458.84m
458.84m 100 FY21 FY22 FY23 FY24 FY25 FY2021 FY2022 · 100 FY2023 · 455.34m FY2024 · 457.25m FY2025 · 458.84m
  FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $17.6B $18.3B $19.6B $19.7B $20.6B
Gross margin 41% 39% 41% 42% 40%
Operating income $2.8B $2.5B $2.4B $2.6B $2.8B
Net income $2.2B $1.9B $1.6B $2.0B $2.1B
Net margin 13% 10% 8% 10% 10%
Earnings per share $4.95 $4.22 $3.42 $4.34 $4.55
Free cash flow $1.4B $1.8B $1.7B $1.6B $1.5B
Free cash margin 8% 10% 9% 8% 7%
Cash $561.0M $1.4B $2.5B $2.9B $4.5B
Long-term debt — $8.2B $8.4B $7.4B $9.5B
Shareholders' equity $16.7B $9.4B $7.1B $8.4B $10.4B
Shares outstanding — 100 455.34m 457.25m 458.84m

What options price now

Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
$70 – $83 ±8.3% by Nov 27, 2026
Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
About the same 30.4% priced · 32.0% recent
Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
Choppier
Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
past week: costs less
Positioning
Premium traded
$781,796 calls $700,904 · puts $80,892 · latest session
Puts against calls, by premium Money spent on puts divided by money spent on calls. Measured in dollars rather than contracts on purpose: counting contracts treats a hundred cheap lottery tickets as more meaningful than one large position, which is backwards. Methodology
0.12× +0.04 over the week
Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
calls +521 · puts -1.98k past week

For options traders: ATM IV 30.4% (-8.1% 1w) · 1m ÷ 3m IV 1.08 · 25Δ skew 2.2 pts · Net GEX $4.3M

Most traded contracts

No contract passed the liquidity filters this week.

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 28, 2026 Quarterly ↗ Sep 30, 2026 28d
Jul 29, 2026 Quarterly ↗ Jun 30, 2026 29d
Apr 29, 2026 Quarterly ↗ Mar 31, 2026 29d
Feb 4, 2026 Annual ↗ Dec 31, 2025 35d
Oct 29, 2025 Quarterly ↗ Sep 30, 2025 29d
Jul 30, 2025 Quarterly ↗ Jun 30, 2025 30d
Apr 30, 2025 Quarterly ↗ Mar 31, 2025 30d
Feb 13, 2025 Annual ↗ Dec 31, 2024 44d
Oct 30, 2024 Quarterly ↗ Sep 30, 2024 30d
Jul 31, 2024 Quarterly ↗ Jun 30, 2024 31d
Apr 30, 2024 Quarterly ↗ Mar 31, 2024 30d
Feb 6, 2024 Annual ↗ Dec 31, 2023 37d

Current reports

FiledDisclosed
Oct 28, 2026 Results · Director or officer change ↗
Sep 22, 2026 Director or officer change · Regulation FD ↗
Aug 18, 2026 Director or officer change ↗
Jul 29, 2026 Regulation FD ↗
Jul 29, 2026 Results ↗
Jul 23, 2026 Results · Director or officer change ↗
May 11, 2026 Shareholder vote · Other events ↗
Apr 29, 2026 Results ↗
Mar 17, 2026 Director or officer change · Regulation FD ↗
Feb 27, 2026 Material agreement · Agreement ended · New obligation ↗
Feb 4, 2026 Results ↗
Dec 15, 2025 Material agreement · New obligation · Other events ↗